XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses        
General and administrative $ 4,500 $ 2,792 $ 10,266 $ 8,382
Research and development 9,959 11,811 30,298 30,224
Total operating expenses 14,459 14,603 40,564 38,606
Operating loss (14,459) (14,603) (40,564) (38,606)
Other income (expense)        
Grant income 25 37
Research and development incentive income 127 526 635 1,591
Interest income, net 1,075 1,796 3,679 5,561
Foreign exchange gain (loss) (11) 67 (337) 72
Total other income, net 1,216 2,389 4,014 7,224
Net loss and comprehensive loss $ (13,243) $ (12,214) $ (36,550) $ (31,382)
Net Loss per share        
Net Loss per share, Basic $ (0.16) $ (0.14) $ (0.43) $ (0.38)
Net Loss per share, Diluted $ (0.16) $ (0.14) $ (0.43) $ (0.38)
Weighted average number of shares outstanding        
Weighted average number of shares outstanding, Basic 85,380,587 84,535,328 85,085,795 83,022,330
Weighted average number of shares outstanding, Diluted 85,380,587 84,535,328 85,085,795 83,022,330